Runping Liu, Yajing Li, Qi Zheng, Mingning Ding, Huiping Zhou, & Xiaojiaoyang Li. (2024). Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead. Elsevier.
Chicago Style (17th ed.) CitationRunping Liu, Yajing Li, Qi Zheng, Mingning Ding, Huiping Zhou, and Xiaojiaoyang Li. Epigenetic Modification in Liver Fibrosis: Promising Therapeutic Direction with Significant Challenges Ahead. Elsevier, 2024.
MLA (9th ed.) CitationRunping Liu, et al. Epigenetic Modification in Liver Fibrosis: Promising Therapeutic Direction with Significant Challenges Ahead. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.